The Business Research Company’s report on the Pediatric And Neonatal Testing Kit Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How have key drivers contributed to the rapid growth of the pediatric and neonatal testing kit market?
The increased prevalence of congenital disorders in newborn babies is driving the pediatric and neonatal testing kit market going forward. Congenital disorders occur during fetal development or are present at birth. Pediatric and neonatal screening is beneficial in detecting the presence of any congenital disabilities and helps healthcare professionals treat those defects at an early stage. For instance, in February 2023, according to the World Health Organization (WHO), a Switzerland-based specialized health agency of the United Nations, approximately 240,000 babies in the world die within the first 28 days of birth due to congenital disorders every year. About 170,000 children die between the ages of 1 month to 5 years due to congenital conditions. Therefore, the increasing prevalence of congenital disorders drives the pediatric and neonatal testing kits market.
Access Your Free Sample of the Global Pediatric And Neonatal Testing Kit Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12198&type=smp
How has the pediatric and neonatal testing kit market size evolved, and what are the latest forecasts for its expansion?
The pediatric and neonatal testing kit market size has grown strongly in recent years. It will grow from $3.91 billion in 2024 to $4.21 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to advancements in pediatric and neonatal care, increased focus on child health, expansion of healthcare infrastructure, growing awareness of prenatal testing, and evolving regulatory landscape
The pediatric and neonatal testing kit market size is expected to see strong growth in the next few years. It will grow to $6.04 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to a rise in demand for non-invasive testing methods, expansion of point-of-care testing in pediatrics, increasing investments in neonatal and pediatric research, and adoption of digital health solutions. Major trends in the forecast period include the development of rapid and accurate testing kits, implementation of next-generation sequencing in pediatric diagnostics, expansion of newborn screening programs, increasing focus on metabolic testing in neonates, and integration of artificial intelligence in diagnostic tools.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12198&type=smp
Which major companies dominate the pediatric and neonatal testing kit market?
Major companies operating in the pediatric and neonatal testing kit market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC, Luminex Corporation, Meridian Bioscience Inc., MP Biomedicals LLC, ELITech Group SAS, Baebies Inc., Labsystems Diagnostics Oy, Advacare Pharma LLP, Beckman Coulter Inc., JETA Molecular BV, EpigenTek Group Inc., ZenTech SA, Hangzhou Testsea Biotechnology Co. Ltd.
What trends will shape the future of the pedestrian bridge market?
The development of novel screening tests is a key trend gaining popularity in the pediatric and neonatal testing kits market. Major companies in the market are focusing on developing novel screening kits, such as mass screening tests, to sustain their position in the market. For instance, in May 2024, Shimadzu Techno-Research, Inc., a Japan-based contract analysis company launched a new contract service to conduct PCR testing for enhanced newborn mass screening. The service provides testing for serious rare diseases, including Severe Combined Immunodeficiency (SCID), B-cell Deficiency (BCD), and Spinal Muscular Atrophy (SMA). It aims to identify these conditions shortly after birth, facilitating prompt intervention and treatment to enhance health outcomes for newborns. At present, the service is offered in 40 out of Japan’s 47 prefectures, with initiatives underway to broaden testing to all newborns through public funding. By partnering with hospitals and delivery facilities, STR seeks to improve the health and welfare of newborns throughout Japan.
Which region dominates the pediatric and neonatal testing kit market, and what factors contribute to its leadership?
North America was the largest region in the pediatric and neonatal testing kit market in 2024. The regions covered in the pediatric and neonatal testing kit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
How is the pediatric and neonatal testing kit market segmented, and which segment holds the largest share?
The pediatric and neonatal testing kit market covered in this report is segmented –
1) By Test Type: Dried Blood Spot, Hearing Screening, Critical Congenital Heart Defect (CCHD), Other Test Types
2) By Product: Assay Kits And Reagents, Instruments
3) By Technology: Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-Based Assays, DNA Based Assays, Electrophoresis, Others Technologies
4) By End User: Hospitals, Diagnostic Centers, Maternity And Specialty Clinics, Other End Users
Subsegments:
1) By Dried Blood Spot: Newborn Screening Panels, Genetic Testing, Infectious Disease Screening
2) By Hearing Screening: Automated Auditory Brainstem Response (ABR) Tests, Otoacoustic Emissions (OAE) Tests, Portable Hearing Screening Devices
3) By Critical Congenital Heart Defect (CCHD): Pulse Oximetry Screening Kits, Echocardiography Screening Tools, Clinical Assessment Protocols
4) By Other Test Types: Blood Gas Analysis Kits, Urine Testing Kits, Infectious Disease Testing, Point-of-Care Testing Devices
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12198
How is the pediatric and neonatal testing kit market defined?
A pediatric and neonatal testing kit refers to a collection of medical devices, instruments, and tools specifically designed and curated for assessing and diagnosing infants, newborns, and children. These kits are used by healthcare professionals, such as pediatricians, neonatologists, nurses, and other medical staff, to aid in diagnosing, monitoring, and treating infants and children.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
